NCT04234113 2026-03-27Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsSotio Biotech Inc.Phase 1 Terminated115 enrolled 43 charts
NCT03816332 2025-10-09Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic CancersNational Cancer Institute (NCI)Phase 1 Active not recruiting12 enrolled 13 charts